“Elon Musk Faces Scrutiny: Allegations of Drug Use Raise Eyebrows Among Tesla and SpaceX Directors”
A recent report by the Wall Street Journal has brought to light concerns about Elon Musk’s alleged use of illegal drugs, a matter supposedly known to several current and former directors of Tesla Inc. and SpaceX. The report suggests that there was unease surrounding the extent of Musk’s drug use, with claims that he consumed drugs in the company of some board members.
Despite these purported concerns, neither Tesla Inc. nor SpaceX conducted formal investigations into Musk’s alleged drug use, and there is no documented evidence of any official board discussions on the matter, according to sources cited by the Wall Street Journal.
Elon Musk, known for his unconventional approach and candid statements, took to social media last month to address the allegations. In a post on X, he quipped, “Whatever I’m doing, I should obviously keep doing it!” Musk playfully acknowledged the speculation about his drug use and humorously suggested that if drugs genuinely enhanced his productivity, he would consider taking them.
The report comes at a time when Elon Musk oversees six companies, including Tesla and SpaceX, renowned as the world’s most valuable car and space companies, respectively. His portfolio also includes X (formerly known as Twitter), The Boring Co. focusing on tunneling ventures, Neuralink dedicated to brain implants, and xAI, an artificial intelligence startup.
As these allegations surface, they raise questions about corporate governance, accountability, and the impact of personal choices on leadership in high-profile companies helmed by figures like Musk. The unfolding narrative adds another layer of complexity to the intricate world of Musk’s multi-industry ventures.
